Ligand Pharmaceuticals Inc (NASDAQ:LGND)

136.42
Delayed Data
As of 4:00pm ET
 +4.20 / +3.18%
Today’s Change
78.26
Today|||52-Week Range
219.75
+37.17%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Higgins John L
Chief Executive Officer
Sale2/05/202154,666$203.40$11.1M-32.87%
Higgins John L
Chief Executive Officer
Sale1/25/202150,000$159.00$8.0M-12.64%
Foehr Matthew William
President & Chief Operating Officer
Sale2/04/202144,547$176.86$7.9M-24.33%
Higgins John L
Chief Executive Officer
Sale1/27/202140,000$182.00$7.3M-16.36%
Berkman Charles Stuart /vernalis/
General Counsel & Senior Vice President
Sale2/04/202118,097$178.50$3.2M-24.33%
Sabba Stephen L
Director
Sale2/09/202114,114$208.55$2.9M-36.85%
Davis Todd C
Director
Sale2/10/20215,083$213.14$1.1M-35.36%
Foehr Matthew William
President & Chief Operating Officer
Buy2/04/202144,547$21.92$976.5K-24.33%
Higgins John L
Chief Executive Officer
Buy2/05/202154,666$14.47$791.0K-32.87%
Higgins John L
Chief Executive Officer
Buy1/25/202150,000$14.47$723.5K-12.64%
Page of 8